Haemodynamic changes following treatment of subclinical and overt hyperthyroidism

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. / Faber, J; Wiinberg, N; Schifter, S; Mehlsen, J.

In: European Journal of Endocrinology, Vol. 145, No. 4, 01.10.2001, p. 391-6.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Faber, J, Wiinberg, N, Schifter, S & Mehlsen, J 2001, 'Haemodynamic changes following treatment of subclinical and overt hyperthyroidism', European Journal of Endocrinology, vol. 145, no. 4, pp. 391-6.

APA

Faber, J., Wiinberg, N., Schifter, S., & Mehlsen, J. (2001). Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. European Journal of Endocrinology, 145(4), 391-6.

Vancouver

Faber J, Wiinberg N, Schifter S, Mehlsen J. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. European Journal of Endocrinology. 2001 Oct 1;145(4):391-6.

Author

Faber, J ; Wiinberg, N ; Schifter, S ; Mehlsen, J. / Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. In: European Journal of Endocrinology. 2001 ; Vol. 145, No. 4. pp. 391-6.

Bibtex

@article{e78166d83a2744e0810817a5805712e5,
title = "Haemodynamic changes following treatment of subclinical and overt hyperthyroidism",
abstract = "Hyperthyroidism has profound effects on the cardiovascular system, including reduced systemic vascular resistance (SVR) due to relaxation of vascular smooth muscle cells, enhanced heart rate (HR) and cardiac output (CO) due to an increase in cardiac diastolic relaxation, contractility and heart rate. Subclinical hyperthyroidism is characterised by reduced serum TSH levels despite free thyroxine (T4) and tri-iodothyronine (T3) estimates within the reference range, in subjects with no obvious symptoms of hyperthyroidism. We measured haemodynamic changes (using impedance cardiography) in subjects with endogenous subclinical hyperthyroidism in order to elucidate whether these patients had signs of excess thyroid hormone at the tissue level.",
author = "J Faber and N Wiinberg and S Schifter and J Mehlsen",
year = "2001",
month = oct,
day = "1",
language = "English",
volume = "145",
pages = "391--6",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "4",

}

RIS

TY - JOUR

T1 - Haemodynamic changes following treatment of subclinical and overt hyperthyroidism

AU - Faber, J

AU - Wiinberg, N

AU - Schifter, S

AU - Mehlsen, J

PY - 2001/10/1

Y1 - 2001/10/1

N2 - Hyperthyroidism has profound effects on the cardiovascular system, including reduced systemic vascular resistance (SVR) due to relaxation of vascular smooth muscle cells, enhanced heart rate (HR) and cardiac output (CO) due to an increase in cardiac diastolic relaxation, contractility and heart rate. Subclinical hyperthyroidism is characterised by reduced serum TSH levels despite free thyroxine (T4) and tri-iodothyronine (T3) estimates within the reference range, in subjects with no obvious symptoms of hyperthyroidism. We measured haemodynamic changes (using impedance cardiography) in subjects with endogenous subclinical hyperthyroidism in order to elucidate whether these patients had signs of excess thyroid hormone at the tissue level.

AB - Hyperthyroidism has profound effects on the cardiovascular system, including reduced systemic vascular resistance (SVR) due to relaxation of vascular smooth muscle cells, enhanced heart rate (HR) and cardiac output (CO) due to an increase in cardiac diastolic relaxation, contractility and heart rate. Subclinical hyperthyroidism is characterised by reduced serum TSH levels despite free thyroxine (T4) and tri-iodothyronine (T3) estimates within the reference range, in subjects with no obvious symptoms of hyperthyroidism. We measured haemodynamic changes (using impedance cardiography) in subjects with endogenous subclinical hyperthyroidism in order to elucidate whether these patients had signs of excess thyroid hormone at the tissue level.

M3 - Journal article

VL - 145

SP - 391

EP - 396

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 4

ER -

ID: 34079140